Healthcare · NIFTY 500
Sai Life Sciences Limited
NSESAILIFE
BSE544306 ISININE570L01029 SeriesEQ Listed on NSE · BSE
₹1,928.80 +23.60 (+1.24%) Updated 13 Nov, 9:19 pm IST
Price, daily close+93.38% in a year
Today
- Open
- ₹1,830.00
- Prev close
- ₹1,905.20
- Day high
- ₹1,954.80
- Day low
- ₹1,820.00
- Volume
- 15.05 L
- Value traded
- ₹290.26 Cr
- Upper circuit
- ₹2,286.20
- Lower circuit
- ₹1,524.20
- 52W high
- ₹1,928.80
- 52W low
- ₹783.85
- 1 month
- +18.56%
- 6 months
- +58.51%
52W low52W high
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Market cap₹40,972 Cr
P/E (TTM)109.72
P/B15.24
Book value / share₹126.54
EPS (TTM)₹17.58
ROE7.5%
Dividend yield—
Dividend (12m)—
Net margin (TTM)8.5%
Operating margin28.3%
Debt / equity0.17
Current ratio1.22
EV / EBITDA59.92
Sales growth (YoY qtr)+22.53%
Profit growth (YoY qtr)—
Sales CAGR 3Y—
Profit CAGR 3Y—
Shares21.24 Cr
Quarterly results
Results for each quarter
Last 8 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Revenue · QoQ (vs last quarter)
—+32%-14%+8.3%+3.5%+8.2%-7.9%+19%
Revenue · YoY (vs a year ago)
————+27%+3.9%+12%+23%
Net profit · QoQ (vs last quarter)
——-32%-100%——-100%—
Net profit · YoY (vs a year ago)
—————+18%-100%—
RevenueNet profitLine = trend
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
EPS (₹) · YoY (vs a year ago)
————+66%+18%+21%+17%
EPS (₹)Line = trend
| ₹ Cr | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 440 | 580 | 496 | 537 | 556 | 602 | 554 | 659 |
| Other income | 9.1 | 9.6 | 9.9 | 15.3 | 8.4 | 15.5 | 3.5 | 4.0 |
| Total income | 449 | 589 | 506 | 553 | 565 | 618 | 558 | 663 |
| Raw material | 122 | 157 | 160 | 204 | 114 | 159 | 178 | 170 |
| Purchases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Employee cost | 133 | 151 | 161 | 163 | 173 | 187 | 180 | 198 |
| Other expenses | 66.3 | 103 | 73.8 | 88.7 | 67.7 | 77.2 | 81.5 | 99.5 |
| Total expenses | 377 | 470 | 426 | 441 | 422 | 479 | 460 | 531 |
| Operating profit | 120 | 158 | 121 | 146 | 180 | 177 | 148 | 186 |
| OPM % | 27.2% | 27.2% | 24.4% | 27.1% | 32.3% | 29.4% | 26.7% | 28.3% |
| Finance cost | 23.1 | 10.9 | 12.4 | 9.4 | 9.7 | 7.8 | 7.6 | 10.9 |
| Depreciation | 34.1 | 37.5 | 37.7 | 39.7 | 44.1 | 45.3 | 45.9 | 48.1 |
| Exceptional items | — | — | — | — | -8.3 | 0.3 | — | — |
| Profit before tax | 71.6 | 119 | 80.7 | 112 | 134 | 139 | 98.0 | 131 |
| Tax | 17.8 | 30.5 | 20.3 | 28.2 | 33.8 | 35.0 | 24.7 | 33.0 |
| Net profit | 53.9 | 88.3 | 60.5 | 83.8 | 100 | 104 | 73.3 | 98.3 |
| Profit to shareholders | 0.0 | — | — | 0.0 | 0.0 | — | 0.0 | — |
| EPS (₹) | 2.84 | 4.14 | 2.83 | 3.93 | 4.71 | 4.87 | 3.42 | 4.58 |
Profit & loss
Results for each year
2 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
FY25
FY26
Revenue · YoY (vs a year ago)
—+29%
Net profit · YoY (vs a year ago)
—+105%
RevenueOperating profitNet profitLine = trend
| ₹ Cr | FY25 | FY26 |
|---|---|---|
| Revenue | 1,695 | 2,192 |
| Other income | 36.8 | 49.1 |
| Total expenses | 1,504 | 1,767 |
| Employee cost | 549 | 683 |
| Operating profit | 406 | 623 |
| OPM % | 23.9% | 28.4% |
| Finance cost | 76.2 | 39.2 |
| Depreciation | 139 | 167 |
| Profit before tax | 228 | 466 |
| Tax | 57.6 | 117 |
| Tax rate % | 25.3% | 25.2% |
| Net profit | 170 | 349 |
| Net margin % | 10.0% | 15.9% |
| EPS (₹) | 8.61 | 16.43 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Mar 25
Mar 26
Sep 26
Shareholders' equity · YoY (vs a year ago)
—+17%—
Shareholders' equityBorrowingsCashLine = trend
| ₹ Cr | Mar 25 | Mar 26 | Sep 26 |
|---|---|---|---|
| Shareholders' equity | 2,128 | 2,484 | 2,688 |
| Long-term borrowings | 0.0 | 20.5 | 30.3 |
| Short-term borrowings | 129 | 74.6 | 418 |
| Total borrowings | 129 | 95.1 | 448 |
| Current liabilities | 732 | 834 | 1,185 |
| Fixed assets (PPE) | 1,477 | 1,809 | 2,028 |
| Inventories | 119 | 151 | 242 |
| Trade receivables | 355 | 374 | 342 |
| Cash & equivalents | 91.1 | 81.9 | 30.9 |
| Current assets | 1,505 | 1,411 | 1,441 |
| Total assets | 3,160 | 3,626 | 4,202 |
| Debt / equity | 0.06 | 0.04 | 0.17 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
FY25
FY26
Operations · YoY (vs a year ago)
—+62%
OperationsInvestingFinancingLine = trend
| ₹ Cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 314 | 509 |
| Cash from investing | -537 | -395 |
| Cash from financing | 301 | -124 |
| Spent on fixed assets | -369 | -593 |
| Free cash flow | -55.2 | -83.8 |
| Net cash flow | 78.8 | -10.0 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Promoter & groupPublic
Latest (30 Sep 2026)
34.5%promoter
- Promoter & group
- 34.50%
- Public (FIIs, mutual funds, retail…)
- 65.50%
- Promoter change, last quarter
- -0.03 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
No recent corporate actions.
Board meetings
- the financial results for the period ended September 30, 2026
- the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
- SAI LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 06-Aug-2026 to inter-alia consider and approve the Unaudited Fi…
- the Un Audited financial results for the period ended Jun 30, 2026
- SAI LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2026 to inter-alia consider and approve the Audited Fina…
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- Monitoring Agency Report
- Copy of Newspaper Publication
- Analysts/Institutional Investor Meet/Con. Call Updates
- Investor Presentation
- Press Release
- ESOP/ESOS/ESPS
Latest news
Multibagger stock: Sai Life Sciences surges 9% to record high after Q2 nosBusiness Standard · 9 Nov, 11:38 amSai Life Sciences Ltd Peer Comparison – Compare with OthersValue Research · 30 Aug, 6:29 pmDivis Laboratories, Gland Pharma, Sai Life Sciences shares hit 52-week highs; here's whyBusiness Today · 9 Nov, 11:35 amSai Life Sciences (NSEI:SAILIFE) - Stock AnalysisSimply Wall St · 10 Nov, 7:56 amSai Life Sciences Hits Life Time High on Strong OutlookEquitypandit · 2 Sep, 12:30 pmNifty 500: Divi's Labs hits record high as profit jumps 64%; HFCL, TD Power slide at market openCNBC TV18 · 9 Nov, 10:02 amSai Life soars 10%, hits record high on strong Q2 earningsBusiness Standard · 6 Nov, 10:39 amSAI LIFE SCIENCES LIMITED Share Price - Live NSE: SAILIFE Stock Price & ChartUpstox · 5 May, 5:04 pmAbout
About Sai Life Sciences Limited
Sai Life Sciences Limited is listed on the NSE under the symbol SAILIFE and belongs to the Healthcare sector.
Company details
- Company name
- Sai Life Sciences Limited
- NSE symbol
- SAILIFE
- BSE scrip code
- 544306
- ISIN
- INE570L01029
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 18 Dec 2024
- Face value
- ₹1 per share
- Market lot
- 1 share
- Shares issued
- 21.24 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Miscellaneous Commercial Services
- Managing director / CEO
- Krishna Kanumuri
- Chair
- K. Ranga Raju
- Headquarters
- Hyderabad, Telangana, India
- Registered address
- L4-01&02, SLN Terminus Survey, Survey no.133, Gachibowli Miyapur Road, Gachibowli, Hyderabad 500032, Telangana, India
- Founded
- 1999
- Employees
- 5,227
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- sailife.com
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories
₹11,442.00
-0.37%
-
LAURUSLABSLaurus Labs
₹2,424.00
+1.00%
-
APOLLOHOSPApollo Hospitals Enterprise
₹8,526.00
+0.13%
-
SUNPHARMASun Pharmaceutical Industries
₹1,880.00
-0.27%
-
NATCOPHARMNATCO Pharma
₹810.45
+0.20%
-
ACUTAASAcutaas Chemicals
₹4,055.00
+1.47%
-
AUROPHARMAAurobindo Pharma
₹1,823.20
+0.89%
-
ALKEMAlkem Laboratories
₹5,114.00
-3.55%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.